Muhammad Umair Mushtaq
Overview
Explore the profile of Muhammad Umair Mushtaq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shahzad M, Amin M, Khalid M, Kasaeian A, Oskouie I, Yu J, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Jan;
PMID: 39890517
Therapy-related myeloid neoplasms (t-MN), which include acute myeloid leukemia (t-AML), myelodysplastic syndrome (t-MDS), and myelodysplastic/myeloproliferative neoplasms are secondary malignancies occurring as a late complication following chemotherapy or radiation therapy for...
2.
Bansal R, Wiedel A, Hastings R, Boutz F, Abdelhakim H, Ahmed N, et al.
J Clin Apher
. 2025 Jan;
40(1):e70004.
PMID: 39810305
Apheresis is essential to conducting hematopoietic cell transplantation and genetically engineered cellular therapy procedures. Many patients and donors require central venous catheter (CVC) access for apheresis due to lack of...
3.
Shahzad M, Iqbal Q, Amin M, Kasaiean A, Oskouie I, Warraich S, et al.
Transplant Cell Ther
. 2025 Jan;
31(3):172.e1-172.e13.
PMID: 39755255
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potential cure for many hematological malignancies. Historically, older adults were not considered eligible for allo-HCT due to increased toxicity and mortality concerns. This...
4.
Shahzad M, Iqbal Q, Amin M, Irfan S, Warraich S, Anwar I, et al.
Leuk Res
. 2024 Dec;
148():107640.
PMID: 39724831
Background: Hematopoietic stem cell transplantation (HCT) is a pivotal treatment modality for primary plasma cell leukemia (pPCL). We aimed to examine the outcomes of allogeneic (allo) and autologous (auto) HCT...
5.
Zulfiqar F, Shahzad M, Amin M, Vyas A, Sarfraz Z, Zainab A, et al.
Transpl Immunol
. 2024 Oct;
87:102137.
PMID: 39442586
Background: Chimeric antigen receptor T cell (CAR-T) therapy is an emerging form of immunotherapy that has recently gained recognition for treating hematological malignancies. This successful utilization of CAR-T therapy has...
6.
Shahzad M, Khan M, Amin M, Sarfraz Z, Zulfiqar F, Qasim H, et al.
Transpl Immunol
. 2024 Oct;
87:102135.
PMID: 39368752
Background: Idiopathic Pneumonia Syndrome (IPS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-threatening complication with high morbidity and mortality. IPS is thought to arise from damage caused by...
7.
Khaliq A, Wesson W, Logan E, Tabak C, Mushtaq M, Lin T, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Jun;
24(10):e344-e349.
PMID: 38910060
Introduction: Existing literature suggests that women are significantly underrepresented in the field of hematology-oncology. Women make up 35.6% of hematologists and data on females as site investigators for pivotal trials...
8.
Wesson W, Dima D, Suleman N, Saif M, Tabak C, Logan E, et al.
Transplant Cell Ther
. 2024 Jun;
30(9):876-884.
PMID: 38871056
BCMA-directed chimeric antigen receptor T-cell (CAR T) therapies, including idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel), have transformed the treatment landscape for relapsed-refractory multiple myeloma (RRMM), offering remarkable efficacy with...
9.
Shahzad M, Amin M, Bellman P, Al-Ramahi J, Noor J, Vyas A, et al.
Transfusion
. 2024 Jun;
64(8):1402-1406.
PMID: 38847196
Background: Nivestym, a biosimilar granulocyte colony-stimulating factor (G-CSF) to the originator filgrastim (Neupogen), is now being used for the mobilization of peripheral blood stem cells (PBSC) in allogeneic hematopoietic stem...
10.
Bellman P, Gonzalez-Lugo J, Shahzad M, Amin M, Khalid M, Suleman N, et al.
Front Oncol
. 2024 Apr;
14:1383730.
PMID: 38665946
Vacuoles, E1 syndrome, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a chronic inflammatory disorder that affects various organ systems. It is associated with hematologic malignancies and is generally refractory to therapies....